Millions of mothers and infants continue to die from complications associated with pregnancy and childbirth annually, with sub-Saharan Africa and Southeast Asia accounting for the most (86%) maternal deaths. Several medicines are available to treat life-threatening conditions that can develop during childbirth.
Strengthening the medicine supply chain is a global imperative and one to which USP has long been committed. Our efforts to help strengthen the medicine supply chain aligns directly with our mission to advance the supply of quality-assured medicines to improve the health and wellbeing of people around the world.
We have an incredible opportunity to leverage the lessons of the last year to make an even greater impact in 2022. At USP, we are resolving to accelerate our global health efforts in four central areas.